Evaluation of the Efficacy and Safety of Nal-IRI for Progressing Brain Metastases in Breast Cancer Patients

Clinical trial NCT03328884 · COMPLETED

Trial details

NCT number: NCT03328884
Sponsor: MedSIR
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Metastatic

Start date: 2017-05-02
Primary completion: 2018-08-31
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.